查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889362

2025年直接抗人類球蛋白試驗（DCT）抗體全球市場報告

Direct Coombs Test (DCT) Antibody Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，直接抗人球蛋白試驗（DCT）抗體市場規模快速成長，預計將從2024年的58.7億美元成長到2025年的65.5億美元，複合年成長率（CAGR）為11.7%。過去幾年的成長可歸因於新生兒溶血病患病率的上升、自體免疫溶血性貧血診斷率的增加、輸血程序的擴展、醫院血庫容量的擴大以及產前篩檢計畫的增加。

預計未來幾年，直接抗人球蛋白試驗（DCT）抗體市場將快速成長，到2029年市場規模將達到100.6億美元，複合年成長率（CAGR）為11.3%。預測期內的成長要素包括人口老化加劇、腫瘤和血液疾病治療量增加、私人診斷檢測網路擴張、通用血型鑑定和交叉配對試驗血需求上升，以及溶血性輸血反應篩檢加大。預測期內的關鍵趨勢包括：聚合酵素鏈鎖反應（PCR）血液基因分型與血清學檢測流程的整合、基於人工智慧的品管和批次放行分析、物聯網（IoT）在低溫運輸監控和追溯方面的應用、雲端基礎實驗室資訊管理系統的普及，以及延長保存期限凍乾技術和穩定劑化學的進步。

未來，對個人化醫療日益成長的需求預計將推動直接抗人類球蛋白試驗（DCT）抗體市場的成長。個人化醫療是一種基於患者的遺傳、環境和生活方式因素來制定個人化治療方案的醫療方法，旨在最佳化治療效果並改善護理。基因組技術的進步使得精準識別基因突變和製定個人化治療方案成為可能，從而推動了對個人化醫療的需求。直接抗人類球蛋白試驗（DCT）抗體透過精準檢測與紅血球結合的抗體和補體，為個人化醫療提供支援。這有助於識別免疫介導的溶血性疾病，並使臨床醫生能夠根據患者特定的免疫特徵制定個人化治療方案，從而提高診斷準確性和治療效果。例如，根據美國非營利組織個人化醫療聯盟（PMC）的數據，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了26種新的個人化藥物，比2022年的12種大幅增加。因此，對個人化醫療日益成長的需求正在推動直接庫姆斯試驗（DCT）抗體市場的成長。

直接抗球蛋白試驗 (DCT) 抗體市場的主要企業正致力於開發技術先進的解決方案，例如基於凝膠的免疫檢測，以確保檢測的可靠性，簡化實驗室工作流程，並維持輸血前檢測的高標準。基於凝膠的免疫檢測是指抗體和抗原在凝膠基質中相互作用的檢測方法，從而可以直覺地檢測凝集等反應。例如，2025 年 10 月，美國體外診斷公司 QuidelOrtho Corporation 的 MTS DAT 卡獲得了美國食品藥物管理局(FDA) 的核准。 MTS DAT 卡是一種基於 ORTHO VISION 平台的凝膠直接抗球蛋白檢測。本產品包含一張即用型卡片，卡片上含有分別置於獨立微管中的抗 IgG 和抗 C3d 單特異性試劑，這些試劑包裹在凝膠基質中。這種設計能夠明確、客觀地同時區分 IgG 和補體致敏，從而簡化免疫介導的溶血性貧血以及胎兒和新生兒溶血病的檢測流程。它的主要目的是檢測與​​紅血球結合的免疫球蛋白 G 或補體，從而幫助調查溶血並提高輸血安全性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球直接庫姆斯試驗（DCT）抗體：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：成長率分析
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場表現：規模與成長，2019-2024年
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場預測：規模與成長，2024-2029年，2034年
  • 全球直接抗人類球蛋白試驗（DCT）抗體：總潛在市場（TAM）

第6章 市場細分

  • 全球直接抗人類球蛋白試驗（DCT）抗體市場按類型、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 單株抗體
  • 多株抗體
  • 重組抗體
  • 雙特異性抗體
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：依來源、效能和預測，2019-2024年、2024-2029、2034年
  • 人類
  • 老鼠
  • 兔子
  • 其他哺乳動物
  • 重組來源
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：依應用、效能和預測分類，2019-2024年、2024-2029、2034年
  • 癌症治療
  • 自體免疫疾病
  • 感染疾病
  • 移植排斥
  • 其他
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場依最終用戶、效能和預測分類，2019-2024年、2024-2029、2034年
  • 製藥公司
  • 生技公司
  • 受託研究機構（CRO）
  • 學術研究機構
  • 診斷實驗室
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：單株抗體細分，按類型、效能和預測（2019-2024年、2024-2029年、2034年）
  • 鼠源性單株抗體
  • 兔單株抗體
  • 人源化單株抗體
  • 嵌合體單株抗體
  • 全人源單株抗體
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：多株抗體細分、按類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 兔多株抗體
  • 山羊多株抗體
  • 綿羊多株抗體
  • 雞多株抗體
  • 驢多克隆抗體
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：重組抗體細分、按類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 哺乳動物表現的重組抗體
  • 細菌表現的重組抗體
  • 酵母表現的重組抗體
  • 昆蟲表現的重組抗體
  • 植物表現的重組抗體
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場：雙特異性抗體細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 免疫細胞結合雙特異性抗體
  • 雙可變區雙特異性抗體
  • 交叉形態雙特異性抗體
  • 旋鈕孔狀雙特異性抗體
  • 基於片段的雙特異性抗體

第7章 區域和國家分析

  • 全球直接抗人類球蛋白試驗（DCT）抗體市場按地區、表現和預測分類，2019-2024年、2024-2029、2034年
  • 全球直接抗人類球蛋白試驗（DCT）抗體市場按國家分類、性能和預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 直接抗人類球蛋白試驗（DCT）抗體市場：競爭格局
  • 直接抗人球蛋白試驗（DCT）抗體市場：公司概況
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Bio-Rad Laboratories Inc.

第31章：其他領先和創新企業

  • Fortress Diagnostics Limited
  • Lab-Care Diagnostics (India) Pvt. Ltd.
  • SIFIN Diagnostics GmbH
  • Hemo Bioscience Inc.
  • Rapid Labs Ltd
  • AnaMol Laboratories Pvt. Ltd.
  • Jiangyin Libo BIoTechnology Co. Ltd.
  • MicroSidd India Pvt. Ltd.
  • Atlas Medical GmbH
  • Lorne Laboratories Ltd
  • Sanquin Reagents BV
  • BAG Diagnostics GmbH
  • CE-Immundiagnostika GmbH
  • Biolab Diagnostics (India) Pvt. Ltd.
  • Singapore Biosciences Pte. Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：具有高市場潛力的國家及其策略

  • 2029年直接抗人類球蛋白試驗（DCT）抗體市場：提供新機會的國家
  • 直接抗人類球蛋白試驗（DCT）抗體市場，2029 年：提供新機會的細分市場
  • 直接抗人類球蛋白試驗 (DCT) 抗體市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r39991

A direct coombs test (DCT) antibody is an antibody that targets the dopachrome tautomerase (DCT) protein, also known as tyrosinase related protein 2 (TRP 2). This protein plays an important role in melanin biosynthesis and is commonly used as a marker for melanocyte differentiation and melanoma research. It is widely used to detect, measure, and study DCT expression in biological samples.

The main types of direct coombs test (DCT) antibody include monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and bispecific antibodies. Monoclonal antibodies are laboratory produced molecules created to bind specifically to antigens on red blood cells, allowing accurate detection of immune mediated hemolysis during diagnostic testing. The various sources include human, mouse, rabbit, other mammals, and recombinant sources and are used across applications such as cancer treatment, autoimmune diseases, infectious diseases, transplant rejection, and other related uses. The key end users include pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic and research institutes, and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The direct coombs test (DCT) antibody market research report is one of a series of new reports from The Business Research Company that provides direct coombs test (DCT) antibody market statistics, including direct coombs test (DCT) antibody industry global market size, regional shares, competitors with a direct coombs test (DCT) antibody market share, detailed direct coombs test (DCT) antibody market segments, market trends and opportunities, and any further data you may need to thrive in the direct coombs test (DCT) antibody industry. This direct coombs test (DCT) antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The direct coombs test (DCT) antibody market size has grown rapidly in recent years. It will grow from $5.87 billion in 2024 to $6.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of hemolytic disease of the newborn, increasing autoimmune hemolytic anemia diagnoses, growing blood transfusion procedures, expanding hospital blood bank capacity, and rising antenatal screening programs.

The direct coombs test (DCT) antibody market size is expected to see rapid growth in the next few years. It will grow to $10.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to a growing geriatric population, rising oncology and hematology treatment volumes, expanding private diagnostic laboratory networks, growing demand for universal blood typing and cross matching, and increasing screening for hemolytic transfusion reactions. Major trends in the forecast period include integration of polymerase chain reaction based blood group genotyping with serology workflows, artificial intelligence assisted quality control and lot release analytics, Internet of Things enabled cold chain monitoring and traceability, adoption of cloud based laboratory information management systems, and advances in lyophilization and stabilizer chemistry for extended shelf life.

The rising demand for personalized medicine is expected to propel the growth of the direct coombs test DCT antibody market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Direct coombs test DCT antibody supports personalized medicine by enabling precise detection of antibodies or complement bound to red blood cells. It helps identify immune mediated hemolytic conditions, allowing clinicians to tailor treatments based on a patient's specific immune profile, improving diagnostic accuracy and therapeutic outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition PMC, a US based nonprofit organization, the United States Food and Drug Administration approved twenty six new personalized medicines in 2023, a significant increase from the twelve approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the direct coombs test DCT antibody market.

Major companies operating in the direct coombs test DCT antibody market are focusing on developing technologically advanced solutions such as gel based immunoassays to ensure reliability, enhance laboratory workflow, and maintain high standards in pre transfusion testing. Gel based immunoassays refer to a type of laboratory test in which antibodies and antigens interact within a gel matrix, allowing for visual detection of reactions such as agglutination. For instance, in October 2025, QuidelOrtho Corporation, a US based in vitro diagnostics company, received Food and Drug Administration clearance for MTS DAT Card for gel based direct antiglobulin testing on the ORTHO VISION platform. It features a ready to use card containing anti IgG and anti C3d monospecific reagents in the gel matrix of separate microtubes. This design allows for clear, objective, and simultaneous differentiation between IgG and complement sensitization, streamlining the investigation of immune mediated hemolytic anemias and hemolytic disease of the fetus and newborn. Its core purpose is to detect immunoglobulin G or complement bound to red blood cells, supporting hemolysis investigation and enhancing transfusion safety.

In March 2023, Werfen Life Sciences SA, a Spain based in vitro diagnostics company, acquired Immucor Inc. for approximately two point zero billion dollars. With this acquisition, Werfen aims to strengthen its leadership in transfusion medicine by integrating Immucor's immunohematology portfolio, enhancing automation, expanding global reach, and improving patient safety in hemolysis detection and transfusion management. Immucor Inc. is a US based company specializing in direct coombs test DCT antibody and immunohematology diagnostics.

Major companies operating in the direct coombs test (dct) antibody market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bio-Rad Laboratories Inc., Fortress Diagnostics Limited, Lab-Care Diagnostics (India) Pvt. Ltd., SIFIN Diagnostics GmbH, Hemo Bioscience Inc., Rapid Labs Ltd, AnaMol Laboratories Pvt. Ltd., Jiangyin Libo Biotechnology Co. Ltd., MicroSidd India Pvt. Ltd., Atlas Medical GmbH, Lorne Laboratories Ltd, Sanquin Reagents B.V., BAG Diagnostics GmbH, CE-Immundiagnostika GmbH, Biolab Diagnostics (India) Pvt. Ltd., Singapore Biosciences Pte. Ltd.

North America was the largest region in the direct coombs test (DCT) antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in direct coombs test (DCT) antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the direct coombs test (DCT) antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The direct coombs test (DCT) antibody consists of sales of primary antibodies, secondary antibodies, antibody kits, assay reagents, western blot reagents, enzyme-linked immunosorbent assay (ELISA) kits, immunohistochemistry kits, ready-to-use detection kit, anti- direct coombs test (DCT) (TRP-2), and rabbit monoclonal primary antibody. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Direct Coombs Test (DCT) Antibody Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on direct coombs test (dct) antibody market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for direct coombs test (dct) antibody ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The direct coombs test (dct) antibody market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies; Bispecific Antibodies
  • 2) By Source: Human; Mouse; Rabbit; Other Mammals; Recombinant Sources
  • 3) By Application: Cancer Treatment; Autoimmune Diseases; Infectious Diseases; Transplant Rejection; Other Applications
  • 4) By End-User: Pharmaceutical Companies; Biotechnology Firms; Contract Research Organizations (CROs); Academic And Research Institutes; Diagnostic Laboratories
  • Subsegments:
  • 1) By Monoclonal Antibodies: Mouse Monoclonal Antibodies; Rabbit Monoclonal Antibodies; Humanized Monoclonal Antibodies; Chimeric Monoclonal Antibodies; Fully Human Monoclonal Antibodies
  • 2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies; Goat Polyclonal Antibodies; Sheep Polyclonal Antibodies; Chicken Polyclonal Antibodies; Donkey Polyclonal Antibodies
  • 3) By Recombinant Antibodies: Mammalian Expression Recombinant Antibodies; Bacterial Expression Recombinant Antibodies; Yeast Expression Recombinant Antibodies; Insect Expression Recombinant Antibodies; Plant Expression Recombinant Antibodies
  • 4) By Bispecific Antibodies: Immune Cell Engager Bispecific Antibodies; Dual Variable Domain Bispecific Antibodies; Cross Format Bispecific Antibodies; Knob And Hole Bispecific Antibodies; Fragment Based Bispecific Antibodies
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; AbbVie Inc.; Bio-Rad Laboratories Inc.; Fortress Diagnostics Limited; Lab-Care Diagnostics (India) Pvt. Ltd.; SIFIN Diagnostics GmbH; Hemo Bioscience Inc.; Rapid Labs Ltd; AnaMol Laboratories Pvt. Ltd.; Jiangyin Libo Biotechnology Co. Ltd.; MicroSidd India Pvt. Ltd.; Atlas Medical GmbH; Lorne Laboratories Ltd; Sanquin Reagents B.V.; BAG Diagnostics GmbH; CE-Immundiagnostika GmbH; Biolab Diagnostics (India) Pvt. Ltd.; Singapore Biosciences Pte. Ltd.
  • Countries:

Table of Contents

1. Executive Summary

2. Direct Coombs Test (DCT) Antibody Market Characteristics

3. Direct Coombs Test (DCT) Antibody Market Trends And Strategies

4. Direct Coombs Test (DCT) Antibody Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Direct Coombs Test (DCT) Antibody Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Direct Coombs Test (DCT) Antibody PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Direct Coombs Test (DCT) Antibody Market Growth Rate Analysis
  • 5.4. Global Direct Coombs Test (DCT) Antibody Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Direct Coombs Test (DCT) Antibody Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Direct Coombs Test (DCT) Antibody Total Addressable Market (TAM)

6. Direct Coombs Test (DCT) Antibody Market Segmentation

  • 6.1. Global Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Bispecific Antibodies
  • 6.2. Global Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human
  • Mouse
  • Rabbit
  • Other Mammals
  • Recombinant Sources
  • 6.3. Global Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Treatment
  • Autoimmune Diseases
  • Infectious Diseases
  • Transplant Rejection
  • Other Applications
  • 6.4. Global Direct Coombs Test (DCT) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Contract Research Organizations (CROs)
  • Academic And Research Institutes
  • Diagnostic Laboratories
  • 6.5. Global Direct Coombs Test (DCT) Antibody Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mouse Monoclonal Antibodies
  • Rabbit Monoclonal Antibodies
  • Humanized Monoclonal Antibodies
  • Chimeric Monoclonal Antibodies
  • Fully Human Monoclonal Antibodies
  • 6.6. Global Direct Coombs Test (DCT) Antibody Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rabbit Polyclonal Antibodies
  • Goat Polyclonal Antibodies
  • Sheep Polyclonal Antibodies
  • Chicken Polyclonal Antibodies
  • Donkey Polyclonal Antibodies
  • 6.7. Global Direct Coombs Test (DCT) Antibody Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian Expression Recombinant Antibodies
  • Bacterial Expression Recombinant Antibodies
  • Yeast Expression Recombinant Antibodies
  • Insect Expression Recombinant Antibodies
  • Plant Expression Recombinant Antibodies
  • 6.8. Global Direct Coombs Test (DCT) Antibody Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immune Cell Engager Bispecific Antibodies
  • Dual Variable Domain Bispecific Antibodies
  • Cross Format Bispecific Antibodies
  • Knob And Hole Bispecific Antibodies
  • Fragment Based Bispecific Antibodies

7. Direct Coombs Test (DCT) Antibody Market Regional And Country Analysis

  • 7.1. Global Direct Coombs Test (DCT) Antibody Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Direct Coombs Test (DCT) Antibody Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Direct Coombs Test (DCT) Antibody Market

  • 8.1. Asia-Pacific Direct Coombs Test (DCT) Antibody Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Direct Coombs Test (DCT) Antibody Market

  • 9.1. China Direct Coombs Test (DCT) Antibody Market Overview
  • 9.2. China Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Direct Coombs Test (DCT) Antibody Market

  • 10.1. India Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Direct Coombs Test (DCT) Antibody Market

  • 11.1. Japan Direct Coombs Test (DCT) Antibody Market Overview
  • 11.2. Japan Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Direct Coombs Test (DCT) Antibody Market

  • 12.1. Australia Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Direct Coombs Test (DCT) Antibody Market

  • 13.1. Indonesia Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Direct Coombs Test (DCT) Antibody Market

  • 14.1. South Korea Direct Coombs Test (DCT) Antibody Market Overview
  • 14.2. South Korea Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Direct Coombs Test (DCT) Antibody Market

  • 15.1. Western Europe Direct Coombs Test (DCT) Antibody Market Overview
  • 15.2. Western Europe Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Direct Coombs Test (DCT) Antibody Market

  • 16.1. UK Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Direct Coombs Test (DCT) Antibody Market

  • 17.1. Germany Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Direct Coombs Test (DCT) Antibody Market

  • 18.1. France Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Direct Coombs Test (DCT) Antibody Market

  • 19.1. Italy Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Direct Coombs Test (DCT) Antibody Market

  • 20.1. Spain Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Direct Coombs Test (DCT) Antibody Market

  • 21.1. Eastern Europe Direct Coombs Test (DCT) Antibody Market Overview
  • 21.2. Eastern Europe Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Direct Coombs Test (DCT) Antibody Market

  • 22.1. Russia Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Direct Coombs Test (DCT) Antibody Market

  • 23.1. North America Direct Coombs Test (DCT) Antibody Market Overview
  • 23.2. North America Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Direct Coombs Test (DCT) Antibody Market

  • 24.1. USA Direct Coombs Test (DCT) Antibody Market Overview
  • 24.2. USA Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Direct Coombs Test (DCT) Antibody Market

  • 25.1. Canada Direct Coombs Test (DCT) Antibody Market Overview
  • 25.2. Canada Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Direct Coombs Test (DCT) Antibody Market

  • 26.1. South America Direct Coombs Test (DCT) Antibody Market Overview
  • 26.2. South America Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Direct Coombs Test (DCT) Antibody Market

  • 27.1. Brazil Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Direct Coombs Test (DCT) Antibody Market

  • 28.1. Middle East Direct Coombs Test (DCT) Antibody Market Overview
  • 28.2. Middle East Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Direct Coombs Test (DCT) Antibody Market

  • 29.1. Africa Direct Coombs Test (DCT) Antibody Market Overview
  • 29.2. Africa Direct Coombs Test (DCT) Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Direct Coombs Test (DCT) Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Direct Coombs Test (DCT) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Direct Coombs Test (DCT) Antibody Market Competitive Landscape And Company Profiles

  • 30.1. Direct Coombs Test (DCT) Antibody Market Competitive Landscape
  • 30.2. Direct Coombs Test (DCT) Antibody Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Direct Coombs Test (DCT) Antibody Market Other Major And Innovative Companies

  • 31.1. Fortress Diagnostics Limited
  • 31.2. Lab-Care Diagnostics (India) Pvt. Ltd.
  • 31.3. SIFIN Diagnostics GmbH
  • 31.4. Hemo Bioscience Inc.
  • 31.5. Rapid Labs Ltd
  • 31.6. AnaMol Laboratories Pvt. Ltd.
  • 31.7. Jiangyin Libo Biotechnology Co. Ltd.
  • 31.8. MicroSidd India Pvt. Ltd.
  • 31.9. Atlas Medical GmbH
  • 31.10. Lorne Laboratories Ltd
  • 31.11. Sanquin Reagents B.V.
  • 31.12. BAG Diagnostics GmbH
  • 31.13. CE-Immundiagnostika GmbH
  • 31.14. Biolab Diagnostics (India) Pvt. Ltd.
  • 31.15. Singapore Biosciences Pte. Ltd.

32. Global Direct Coombs Test (DCT) Antibody Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Direct Coombs Test (DCT) Antibody Market

34. Recent Developments In The Direct Coombs Test (DCT) Antibody Market

35. Direct Coombs Test (DCT) Antibody Market High Potential Countries, Segments and Strategies

  • 35.1 Direct Coombs Test (DCT) Antibody Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Direct Coombs Test (DCT) Antibody Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Direct Coombs Test (DCT) Antibody Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer